Concord Medical Services Holdings (FRA:C2C) Operating Margin %: -36.43% (As of Dec. 2025)


FRA:C2C Concord Medical Services Holdings Ltd FRA:C2C
51 GF Score
Price €6.25
GF Value €9.81
! 6 Warning Signs
View Full Analysis

What is Concord Medical Services Holdings Operating Margin %?

Concord Medical Services Holdings FRA:C2C 51 Operating Margin % is -36.43% as of Dec. 2025. GuruFocus rates FRA:C2C with a GF Score™ of 51/100 and a GF Value™ of €9.81. The stock has 6 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Concord Medical Services Holdings ranks worse than 87.54% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Concord Medical Services Holdings's Operating Income for the six months ended in Dec. 2025 was €-11.48 Mil. Concord Medical Services Holdings's Revenue for the six months ended in Dec. 2025 was €31.51 Mil. Therefore, Concord Medical Services Holdings's Operating Margin % for the quarter that ended in Dec. 2025 was -36.43%.

Good Sign:

Concord Medical Services Holdings Ltd operating margin is expanding. Margin expansion is usually a good sign.

The historical rank and industry rank for Concord Medical Services Holdings's Operating Margin % or its related term are showing as below:

FRA:C2C' s Operating Margin % Range Over the Past 10 Years
Min: -182.09   Med: -102.8   Max: -23.62
Current: -51.8


FRA:C2C's Operating Margin % is ranked worse than
87.54% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 4.855 vs FRA:C2C: -51.80

Concord Medical Services Holdings's 5-Year Average Operating Margin % Growth Rate was 10.80% per year.

Concord Medical Services Holdings's Operating Income for the six months ended in Dec. 2025 was €-11.48 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €-28.95 Mil.

Warning Sign:

Concord Medical Services Holdings Ltd has never been profitable in the past 3 years. It lost money every year.


Concord Medical Services Holdings  (FRA:C2C) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Concord Medical Services Holdings Operating Margin % Related Terms


Concord Medical Services Holdings Operating Margin % Historical Data

* Premium members only.

The historical data trend for Concord Medical Services Holdings's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Medical Services Holdings Operating Margin % Chart

Concord Medical Services Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -94.37 -111.22 -86.15 -138.60 -51.97

Concord Medical Services Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -98.45 -90.37 -202.50 -72.11 -36.43

FRA:C2C vs CCEL, GBCS, CDIX: Operating Margin % Comparison

For the Medical Care Facilities subindustry, Concord Medical Services Holdings's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Concord Medical Services Holdings Operating Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Concord Medical Services Holdings's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Concord Medical Services Holdings's Operating Margin % falls into.


FRA:C2C
51GF Score
Concord Medical Services Holdings Ltd FRA:C2C
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Medical Services Holdings Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Concord Medical Services Holdings's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-29.019 / 55.838
=-51.97 %

Concord Medical Services Holdings's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=-11.48 / 31.513
=-36.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -36.43% mean?
Concord Medical Services Holdings (FRA:C2C) has a Operating Margin % of -36.43% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Concord Medical Services Holdings and its competitors. According to the industry distribution chart, Concord Medical Services Holdings ranks #583 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 87.5%.
Is Concord Medical Services Holdings' Operating Margin % too high?
Concord Medical Services Holdings' current Operating Margin % is -36.43%. Based on the distribution chart, Concord Medical Services Holdings ranks #583 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Concord Medical Services Holdings has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Services Holdings' Operating Margin % compare to CCEL and GBCS?
According to the Healthcare Providers & Services industry distribution chart, Concord Medical Services Holdings ranks #583 out of 666 companies for Operating Margin %. This places Concord Medical Services Holdings in the lower half of its industry. The industry median Operating Margin % is 4.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.86, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Concord Medical Services Holdings and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Medical Services Holdings's current Operating Margin % is -36.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Services Holdings stock overvalued right now?
Concord Medical Services Holdings (FRA:C2C) has a current Operating Margin % of -36.43%. The stock's GF Value™ is €9.81, compared to a current price of €6.25 — trading 36.3% below its estimated fair value. The current Operating Margin % is -36.43%. Concord Medical Services Holdings' overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Concord Medical Services Holdings (FRA:C2C), the current Operating Margin % is -36.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Medical Services Holdings (FRA:C2C) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Medical Services Holdings stock appears to be undervalued. The current stock price of €6.25 is trading 36.3% below its estimated GF Value™ of €9.81.

Key valuation signals for FRA:C2C:

  • Operating Margin %: -36.43%
  • GF Value™: €9.81 vs. price of €6.25 (36.3% below fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the FRA:C2C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Concord Medical Services Holdings Business Description

Other Exchanges CCM:USA
Address Hanwei Plaza Building, No. 7 Guanghua Road, Room A1-A5, 26th Floor, East Area, Chaoyang District, Beijing, CHN, 100020
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Geographically, the company derives revenue from PRC.
51GF Score

Get the complete analysis for FRA:C2C

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.25
Price
€9.81
GF Value